Page last updated: 2024-11-02

piribedil and ADDH

piribedil has been researched along with ADDH in 1 studies

Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Turle-Lorenzo, N1
Maurin, B1
Puma, C1
Chezaubernard, C1
Morain, P1
Baunez, C1
Nieoullon, A1
Amalric, M1

Other Studies

1 other study available for piribedil and ADDH

ArticleYear
The dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 319, Issue:2

    Topics: Animals; Antiparkinson Agents; Attention Deficit Disorder with Hyperactivity; Cognition; Corpus Stri

2006